Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum

Journal of Virology

Volumn 84, Issue 2, 2010, Pages 847-855

  Carpenter, J E ^a   Jackson, W ^a   De Souza, G A ^b   Haarr, L ^b   Grose, C ^a  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; ENZYME ANTIBODY; INSULINASE; METALLOPROTEINASE; TUNICAMYCIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME BINDING; GLYCOSYLATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; MASS SPECTROMETRY; NONHUMAN; OPEN READING FRAME; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; VARICELLA ZOSTER VIRUS;

ANIMALS; CELL LINE, TUMOR; CHILD, PRESCHOOL; ENDOPLASMIC RETICULUM; HERPESVIRUS 3, HUMAN; HUMANS; INSULYSIN; PROTEIN PRECURSORS; UNFOLDED PROTEIN RESPONSE; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 3; SIMPLEXVIRUS;

EID: 73849149032     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01801-09     Document Type: Article

References (39)

1. Ali, M. A., Q. Li, E. R. Fischer, and J. I. Cohen. 2009. The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection. Virology 386:270-279.
2. Bernales, S., F. R. Papa, and P. Walter. 2006. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol. 22:487-508.
3. Chou, Y. H., W. L. Kuo, M. R. Rosner, W. J. Tang, and R. D. Goldman. 7 July 2009. Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme. FASEB J. 23:3734-3742. [Epub ahead of print.]
4. de Souza, G. A., H. Malen, T. Softeland, G. Saelensminde, S. Prasad, I. Jonassen, and H. G. Wiker. 2008. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 9:316.
5. de Souza, G. A., T. Softeland, C. J. Koehler, B. Thiede, and H. G. Wiker. 2009. Validating divergent ORF annotation of the Mycobacterium leprae genome through a full translation data set and peptide identification by tandem mass spectrometry. Proteomics 9:3233-3243.
6. Duckworth, W. C., R. G. Bennett, and F. G. Hamel. 1998. Insulin degradation: progress and potential. Endocr. Rev. 19:608-624.
7. Duus, K. M., C. Hatfield, and C. Grose. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210:429-440.
8. Ejercito, P. M., E. D. Kieff, and B. Roizman. 1968. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:357-364.
9. Fawcett, J., and W. C. Duckworth. 2009. Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link? Diabetologia 52:1457-1460.
10. Friedrichs, W. E., and C. Grose. 1984. Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. J. Virol. 49:992-996.
11. Grose, C. 1990. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44:59-80.
12. Grose, C. 2002. The predominant varicella-zoster virus gE and gI glycoprotein complex, p. 195-223. In A. Holzenburg, E. Bogner (ed.), Structurefunction relationships of human pathogenic viruses. Kluwer Academic/Plenum Publishers, New York, NY.
13. Grose, C. 1980. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology 101:1-9.
14. Grose, C., and P. A. Brunel. 1978. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32° C. Infect. Immun. 19:199-203.
15. Grose, C., D. P. Edwards, W. E. Friedrichs, K. A. Weigle, and W. L. McGuire. 1983. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect. Immun. 40:381-388.
16. Grose, C., D. M. Perrotta, P. A. Brunell, and G. C. Smith. 1979. Cell-free varicella-zoster virus in cultured human melanoma cells. J. Gen. Virol. 43:15-27.
17. Grose, C., S. Tyler, G. Peters, J. Hiebert, G. M. Stephens, W. T. Ruyechan, W. Jackson, J. Storlie, and G. A. Tipples. 2004. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J. Virol. 78:6799-6807.
18. Im, H., M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C. Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, and W. J. Tang. 2007. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J. Biol. Chem. 282:25453-25463.
19. Li, Q., M. A. Ali, and J. I. Cohen. 2006. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 127:305-316.
20. Li, Q., T. Krogmann, M. A. Ali, W. J. Tang, and J. I. Cohen. 2007. The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor. J. Virol. 81:8525-8532.
21. Makarov, A. 2000. Electrostatic axially harmonic orbital trapping: a highperformance technique of mass analysis. Anal. Chem. 72:1156-1162.
22. Makarov, A., E. Denisov, A. Kholomeev, W. Balschun, O. Lange, K. Strupat, and S. Horning. 2006. Performance evaluation of a hybrid linear ion trap/ Orbitrap mass spectrometer. Anal. Chem. 78:2113-2120.
23. McMillan, T. N., and D. C. Johnson. 2001. Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J. Virol. 75:1928-1940.
24. Montalvo, E. A., R. T. Parmley, and C. Grose. 1985. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of Nlinked and O-linked oligosaccharide moieties. J. Virol. 53:761-770.
25. Nakatsukasa, K., and J. L. Brodsky. 2008. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 9:861-870.
26. Nakatsukasa, K., G. Huyer, S. Michaelis, and J. L. Brodsky. 2008. Dissecting the ER-associated degradation of a misfolded polytopic membrane protein. Cell 132:101-112.
27. Olsen, J. V., L. M. de Godoy, G. Li, B. Macek, P. Mortensen, R. Pesch, A. Makarov, O. Lange, S. Horning, and M. Mann. 2005. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell Proteomics 4:2010-2021.
28. Olson, J. K., and C. Grose. 1997. Endocytosis and recycling of varicellazoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J. Virol. 71:4042-4054.
29. Peters, G. A., S. D. Tyler, C. Grose, A. Severini, M. J. Gray, C. Upton, and G. A. Tipples. 2006. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J. Virol. 80:9850-9860.
30. Qiu, W. Q., and M. F. Folstein. 2006. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27:190-198.
31. Rappsilber, J., Y. Ishihama, and M. Mann. 2003. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75:663-670.
32. Santos, R. A., J. A. Padilla, C. Hatfield, and C. Grose. 1998. Antigenic variation of varicella-zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology 249:21-31.
33. Schmitz, A., A. Schneider, M. P. Kummer, and V. Herzog. 2004. Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways. Traffic 5:89-101.
34. Scigelova, M., and A. Makarov. 2006. Orbitrap mass analyzer-overview and applications in proteomics. Proteomics 6(Suppl. 2):16-21.
35. Shii, K., and R. A. Roth. 1986. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc. Natl. Acad. Sci. U. S. A. 83:4147-4151.
36. Takahashi, M. N., W. Jackson, D. T. Laird, T. D. Culp, C. Grose, J. I. Haynes II, and L. Benetti. 2009. Varicella-zoster virus infection induces autophagy in both cultured cells and human skin vesicles. J. Virol. 83:5466-5476.
37. Tavaria, M., T. Gabriele, I. Kola, and R. L. Anderson. 1996. A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones 1:23-28.
38. Tkacz, J. S., and O. Lampen. 1975. Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem. Biophys. Res. Commun. 65:248-257.
39. Vembar, S. S., and J. L. Brodsky. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9:944-957.